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ABSTRACT
INTRODUCTION
The gene PAX9 belongs to a family composed 
of nine genes that encode transcription factor 
proteins, the Pax proteins, characterized by the 
presence of a paired domain, and a highly conserved 
DNA binding region of approximately 128 amino 
acids1,3,13,18 and are essential during later stages of 
tooth development3,10,15,19. It is known that they are 
under the control of Fgf/Bmp signaling5.
PAX9 protein products are essential for the 
establishment of the odontogenic potential of 
mesenchyme, where the expression appears 
to be a marker for the sites of tooth formation 
due to its presence prior to any morphological 
manifestation of this process15. Analysis of mouse 
embryos has shown that PAX9 is an early marker 
of tooth development, appearing at the E10 stage 
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Objectives: PAX9 belongs to the Pax family of transcriptional factor genes. This gene is expressed in embryonic tissues such as somites, pharyngeal pouch endoderm, 
distal limb buds and neural crest-derived mesenchyme. Polymorphisms in the upstream 
promoter region of the human PAX9 have been associated with human non-syndromic 
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 in vitro mRNA expression of this 
gene and the luciferase activity of two constructs containing promoter sequences of the 
PAX9 gene. Material and Methods: Embryonic tissues were obtained from digits, face, 
and midbrain/hindbrain regions. Fragments containing PAX9 promoter sequences were 
cloned into reporter plasmids and were transfected into the different cell cultures. mRNA 
were extracted from primary cell cultures. Results: The semi-quantitative RT-PCR results 
showed that in vitro E13.5 limb bud and CNS cells express PAX9, but cells derived from 
the facial region do not. Moreover, the luciferase assay showed that protein activity of the 
constructed vector was weaker than pgl3 -basic alone. Conclusions: The present results 
		    		    	
  
  
transcription.
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in mesenchyme before the ectodermal thickening 
and prior to the expression of other tooth signaling 
genes. High levels of PAX9 expression are 
subsequently maintained throughout the initiation 
(E11.5), bud, and cap stages and are down 
regulated at the bell stage (E16)5.
The initial description of the tooth agenesis 
caused by the mutation in PAX9 was made by 
Stockton, et al.20 (2000). Since then, many 
others autosomal dominant mutations have been 
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which being located in the paired DNA-binding 
domain of PAX9. Polymorphisms in the upstream 
promoter region of the human PAX9 have been 
associated with variable forms of oligodontia17, 
and mutations in this gene were shown to be 
associated with autosomal dominant forms of 
oligodontia in humans2,3,6,8,16,20,24. To date it is 
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known that heterozygous deletion of entire PAX9 
gene is associated with a severe form of non-
syndromic tooth agenesis that involves all the 
primary molars and some posterior permanent 
teeth (premolars and molars)3,10,11,20. However, the 
precise mechanisms for the development of tooth 
agenesis remain unclear25.
Promoter mutations are known to have 
functionally important consequences for gene 
expression, but promoter analysis is not a regular 
part of molecular diagnostics, and one reason 
is that the effect of promoter mutations can be 
very subtle. Approximately 1% of single basepair 
substitutions causing human genetic diseases 
occur within gene promoter regions where they 
disrupt the normal process of gene activation and 
transcriptional initiation, and usually decrease or 
increase the level of mRNA and, thus, the protein4.
Considering that the promoter of a gene is a 
regulatory region of DNA, and it contains multiple 
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factors, the aim of the present study was to 
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transcription of PAX9 gene. Two fragments of the 
promoter region were cloned on reporter plasmids 
containing the luciferase gene and transfected into 
three different rat embryo tissues: digits, face and 
midbrain/hindbrain regions.
MATERIAL AND METHODS
Construction of Expression Plasmids
The PAX9 promoter region between positions 
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by PCR and subcloned into SacI-HindIII restriction 
sites of TOPO TA vector (Invitrogen) to generate a 
large number of copies for cloning into pGL3-Basic 
vector. The second plasmid was constructed by 
the pGL3-Basic-PAX9 promoter digested with ApaI 
restriction enzyme, resulting in a 691 bp insert 
(pGL3-Basic-PAX9-ApaI, -1106 to -645 and -138 
to +92). In both, the +92 base was oriented to the 
luciferase gene (Figure 1).
Maternal and Fetal Surgical Manipulation
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found. On day 13.5, pregnant females were 
anesthetized with ketamine (100 mg/mL) and, 
following surgery, the animals were euthanized 
by cervical dislocation. The uterus was aseptically 
removed and placed in a 25 mL screw-capped tube 
containing 20 mL phosphate-buffered saline/D-
PBS (Gibco®, Invitrogen, Carlsbad, CA, USA) and 
1% antibiotic solution Antibiotic-Antimycotic liquid 
(100x) (Invitrogen). Embryos were dissected out 
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a fresh dish of sterile PBS. The embryonic digits, 
face, and midbrain and hindbrain regions (these 
cells will be referred to as CNS) were placed in 
35 mm cell culture dishes. The tissue fragments 
collected in facial region contained the maxillary 
and mandibular (including the dental lamina) and 
frontonasal processes. The cells that survived 
the culturing process were stellate resembling 
mesenchymal rather than epithelial type cells.
Experiments were performed in duplicate. The 
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Medium/D-MEM high glucose (Gibco®, Invitrogen) 
supplemented with 10% fetal bovine serum and 
1% antibiotic solution Antibiotic-Antimycotic liquid 
(100x) (Invitrogen) and incubated at 37°C in the 
presence of 5% CO2. Ethical approval was granted 
by the Research Ethics Committee of the Piracicaba 
Dental School.
mRNA analysis
After 48 h of culture, cells were homogenized 
and total RNA was isolated with TRIzol™ reagent, 
following manufacturer’s instructions (Invitrogen, 
Carlsbad, CA, USA). cDNA was synthesized from 
1 g of total RNA using SuperScript III Reverse 
Transcriptase following manufacturer’s instructions 
(Invitrogen, Carlsbad, CA, USA). DNase I digestion of 
RNA was performed prior to the reverse transcriptase 
reaction. In two independent experiments, PCR 
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Figure 1- Construct Pgl3PAX9ApaI was digested with ApaI and re-ligated resulting in a plasmid containing the 691bp (by 
L. L. Ramenzoni)
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as an internal control to monitor transfection 

  
 		  K
sense 5’ (GAGTTCCATCAGCCGGATTC) and PAX9Rat 
antisense 5’ (GATTGGAGAAGGGAGCCTTG), and rat 
beta actin sequences were 5’ TGA CAT CCG TAA AGA 
CCT CT 3’ (sense) and 5’ AGA TGT GAT CAG CAA 
GCA G 3’ (antisense). Polymerase chain reactions 
were performed on a TC-512 PCR machine (Techne 
Incorporated, Burlington, NJ, USA) using 5 L of 
cDNA, 5 picomoles of each oligonuclotides primer, 
and GoTaq® Green Master (Promega Corporation, 
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program was initiated with a 94°C denaturation for 4 
min, followed by 40 cycles of 94°C for 1 min, 50°C for 
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The PCR program for this gene was similar previous 
described, but the annealing temperature used was 
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images were digitally captured and analyzed with the 
ImageJ software (available from http://rsbweb.nih.
gov/ij/).
Transient transfection
Transient transfections were performed when 90-
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using Lipofectamine 2000™ reagent (Invitrogen) in 
the presence of Reduced Serum Medium according 
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Luciferase Reporter Vectors – Basic Vector (Promega 
Corporation) were used for a co-transfection 

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Corporation), kindly provided by Dr. Kleber Franchini 
from UNICAMP, for luciferase analysis normalization. 
Transfected cells were incubated at 37°C in the 
presence of 5% CO2.
Luciferase analysis
At 48 h after transfection, cell extracts were 
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were measured using Dual Glo Luciferase Assay 
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the remaining DMEM serum-free medium were 
mixedwith 75 L of Dual-Glo™ Luciferase Reagent 
(Promega Corporation) and incubated for 1 min. The 
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in 96-well microplate-reading luminometer (Veritas™ 
Microplate Luminometer, Promega Corporation, 
Madison, WI, USA). Each sample was normalized to 
Renilla luciferase absorbance to correct for variations 
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Glo® Reagent (Promega Corporation) added to the 
same well and incubated for 10 min after reading. 
Experiments were performed in duplicate.
RESULTS
mRNA analysis
In the present experiment, a semi-quantitative 
assay RT-PCR was performed to measure the in vitro 
expression of PAX9 gene, using E13.5 rat embryonic 
cells in culture. The results indicated that the PAX9 
gene is not expressed in face at this day, while in 
digits and CNS this gene is expressed (Figure 2). The 
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gene validates our approach, indicating that the gene 
is repressed in face tissues of the analyzed embryos.
Luciferase analysis
The experiments revealed that both transfected 
constructions pGL3/PAX9 plasmids were not able to 
highly express the Luc protein. However, luciferase 
expression was decreased in digits and CNS 
transfected cells, and completely inhibited it in face 
transfected cells (Figure 3), supporting the mRNA 
analysis results.
Figure 2- PAX9 expression in rat embryos cells were 
detected by semi-quantitative PCR in 2% agarose with 
ethidium bromide
Figure 3- Luciferase expression and inhibition evidence in 
rat embryo 13.5 days of digits, face and CNS cells cultures. 
It can be observed that in the digits and CNS cells, the 
Luciferase was down expressed in pGL3PAX9SacI 
transfected cells, and its complete inhibition in 
pGL3PAX9ApaI transfected cells. In face cells, there was 
the complete inhibition of the Luciferase expression of all 
plasmids transfected cells
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DISCUSSION
The dental development involves complex 
series of epithelial and mesenchymal signaling 
interactions, more than 300 genes are involved in 
the process22,23. Among these, transcription factors 
play a prominent role in the development of various 
organs, including teeth. To date, mutations of two 
of these transcription factors, which are associate 
with tooth agenesis, PAX0 and MSX110. While MSX1 
mutations have been reported to involve cleft lip and 
palate5 and Witkop syndrome7, along with missing 
teeth, all known PAX9 mutations are associated 
with nonsyndromic oligodontia that can involve 
all types of permanent teeth, especially molars, 
suggesting that PAX9 plays a dominant role in the 
development of posterior teeth2,3,6,8,9,11,14,20,21,26. 
The application of different strategies in vivo and 
in vitro studies with mice has greatly enabled 
our understanding of the intricate molecular 
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dentition, indispensable for unraveling the genetic 
etiology of human tooth agenesis10. Given the role 
of PAX9 as a transcription factor, the mutations 
may affect multiple functions or processes, such as 
DNA-binding, nuclear translocation, transcriptional 
activation or synergistic protein–protein interactions 
with co-activators such as MSX125. Moreover, two 
non-coding regions which known role in increase 
}		
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19.
pGL3PAX9SacI and pGL3PAX9ApaI constructs 
showed differentially transcriptional activity 
especially in digits and CNS cells. The analysis 
of the DNA biding sites on MatInspector software 
(available from http://www.genomatix.de/cgi-
bin/eldorado/main.pl) revealed that the region of 
deleted in pGL3PAX9ApaI contains more than 80 
putative transcriptional biding sequences, including 
zinc binding proteins, GATA binding factors, 

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kruppel-like transcription factors19
This work analyzed the PAX9 model of 
transcriptional regulation using the promoter 
sequence, as well as the capacities of this region 
to direct and regulates the transcriptional activity 
in primary cell culture derived from embryos 
limbs, face and central system nerve. The results 
demonstrated that that PAX9 gene was expressed in 
embryo E13.5 day limbs and CSN, but surprisingly 
was not expressed in cells derived from facial 
region. Kriangkrai, et al.12 (2006) showed that PAX9 
was expressed on facial region of rats at stages 
E13 and E14. One possible explanation for this 
discrepancy is that the transcription of PAX9 was 
inhibited when facial cells were cultured during two 
days. In fact, one thing that is evidenced in studies 
that analyze the expression of PAX9 in mouse 
and rat embryonic tissues is that the expression 
of this gene changes rapidly during ontogeny12,15. 
Therefore, in vitro
	

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of homeo- and paired domain proteins do not 
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the network of in vivo factors determining DNA-
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consequences is scarcely known25.
CONCLUSIONS
The results of the present study showed that 
the luciferase activity of pGL3-PAX9 constructs 
was weaker than pGL3-Basic vector alone, 
suggesting that PAX9 5’ #
		
	
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and that this region might contain inhibitory cis-
acting sequences. These results also indicate that 
enhancer sequences located in 5’ sequences distant 
from the transcription origin or in intronic regions 
are necessary for PAX9 transcription.
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